COVID All Over Again? Dr. Quay on Nipah Virus, Airport Screening, and Biosecurity Failures

Steve welcomes physician-scientist Dr. Steven Quay to discuss the emerging Nipah virus outbreak overseas and why airports are reverting to COVID-era screening measures. Drawing on his Senate testimony and decades of experience, Quay explains why reactive policies offer false reassurance while real biosecurity risks remain unresolved. The conversation also expands into the dangers of the big food industry, what Americans are really being fed, and praise for RFK Jr. for flipping the public health pyramid on its head.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Dr. Steven Quay joins Tony Mantor’s Why Not Me? podcast to discuss breast cancer prevention, early detection, and hope for women worldwide during Breast Cancer Awareness Month.